During 1988-1994 at the Second Surgical Clinic in Brno and in the surgical department of the Hospital of Merciful Brethren in Valtice a total of 5200 fibroscopic examinations were made incl. 560 on account of haemorrhage into the upper gastrointestinal tract. The purpose of fibroscopy was to detect sites of haemorrhage and treat them, or to establish at least the level of the haemorrhage. Visualization of the source was achieved in 90%, the level was assessed in 7.5% and failure was recorded in 2.5%. By treatment of the source of haemorrhage primary haemostasis was achieved in 83.32%, definitive haemostasis in 77.01%. Endoscopy of acute haemorrhage into the GIT is at present the method of choice when resolving these conditions. Classical procedures involving supplementation of the blood volume and waiting for spontaneous haemostasis should be considered as "non lege artis" procedures.
Download full-text PDF |
Source |
---|
Cureus
January 2025
Department of Gastroenterology and Hepatology, Salmaniya Medical Complex, Manama, BHR.
Background Upper gastrointestinal bleeding (UGIB) is one of the most common major medical emergencies. This study sought to determine the epidemiology, clinical characteristics, and outcomes of UGIB in the largest major tertiary care center in Bahrain, compared to regional and international cohorts. Methods We conducted a retrospective cohort study of all patients diagnosed with UGIB between April 2021 and April 2022 in Salmaniya Medical Complex, Bahrain's largest tertiary-level public hospital.
View Article and Find Full Text PDFInnov Clin Neurosci
December 2024
All authors are with Ocean University Medical Center in Brick, New Jersey.
Introduction: The demographics of the United States (US) are evolving as time progresses. The geriatric population is growing, with many elderly people dealing with mental health issues. Major depressive episodes affect 1 to 5 percent of those aged 65 years or older, which emphasizes the importance of addressing mental health concerns in this populace.
View Article and Find Full Text PDFAnn Thorac Surg Short Rep
December 2024
Department of Surgery, Baylor College of Medicine, Houston, Texas.
Background: The objective of this study was to compare generative artificial intelligence-initiated care pathways, using ChatGPT, with expert-guided consensus-initiated care pathways from AskMayoExpert (AME) for symptom management of esophageal cancer patients after esophagectomy.
Methods: A formal protocol for development of 9 AME care pathways was followed for specific patient-identified domains after esophagectomy for esophageal cancer. Domain scores were measured and assessed through the Upper Digestive Disease tool.
Dig Endosc
January 2025
Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China.
Objectives: Previous research has conducted meta-analyses on the diagnostic accuracy of endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB). However, studies on adverse events (AEs) have been limited and sporadic and have included a highly diverse group of patients (with upper and lower gastrointestinal tract issues) and needles of varying sizes (19-22-25G). The purpose of this systematic review and meta-analysis was to determine the incidence of AEs related to the utilization of 20-22G second-generation EUS-FNB needles subsequent to puncture of the upper gastrointestinal tract and adjacent organs.
View Article and Find Full Text PDFAliment Pharmacol Ther
January 2025
Department of Gastroenterology, Northern Health, Melbourne, Victoria, Australia.
Risk stratification tools for the prediction of complications in patients with upper gastrointestinal haemorrhage are crucial for appropriate management. Blood group status has been associated with the risk of bleeding, thrombosis and risk of peptic ulcer disease (PUD). We assessed the influence of blood group status on rebleeding and other complications in 699 patients with PUD bleeding.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!